Global Microcarrier Market is predicted to reach US$ 3.43 Billion by 2030, at 8.85% CAGR Growth
21 Nov, 2023

Microcarrier Market is anticipated to hit around US$ 3.43 Billion by 2030, driven by increasing demand from the pharmaceutical and biotechnology industries, advancements in research and development, and a rising focus on cell-based therapies

In a report titled "Microcarrier Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030," published recently by Renub Research, market share insights are included along with a thorough industry analysis. The report also includes research on regions, competitors, and the recent expansion of the Microcarrier Market.

Microcarrier Market is projected to grow at a CAGR of 8.85% between 2022 and 2030. The rising demand from pharmaceutical and biotechnology industries significantly shapes the microcarrier market, particularly in vaccine and monoclonal antibody production. This surge has intensified competition among manufacturers, driving innovation and technological advancement. The pharmaceutical and biotechnology sectors' heavy investment in research and development is yielding novel microcarrier products, propelling market growth. Fundamental tendencies encompass the augmentation of production capabilities, advancement of improved microcarrier offerings, cost reduction driven by increased competition and the benefits of scale, and the exploration of novel applications for microcarriers in areas like cell therapies and tissue engineering products.

Moreover, the surge in cell-based therapies is driving an increased demand for microcarriers crucial in their production. These tiny beads, used in bioreactors, provide a significant surface area for cultivating high cell densities in a compact volume, essential for therapies requiring billions or trillions of cells. The growing emphasis on cell-based therapies significantly impacts the global microcarrier market, leading to rapid growth and the development of tailored products and technologies for cell therapy manufacturers. Trends include expanding microcarrier portfolios for cell therapy applications, creating biodegradable and three-dimensional cell culture microcarriers, decreasing prices due to heightened competition, and applying microcarriers in innovative processes like producing chimeric antigen receptor T-cells (CAR T-cells).

Report Details:

Due to the high purchase frequency and increasing demand for cell-based therapies, the consumables segment is the fastest-growing segment in themicrocarrier market.

The consumables segment in the microcarrier market undergoes continual replenishment, driven by the regular demand for items like microcarrier beads, media, and reagents to sustain cell cultures. The prominence of cell-based therapies and the rapid expansion of the biopharmaceutical industry intensify this demand. Technological advancements significantly enhance microcarrier beads and contributes to increased consumable usage. The growing adoption of single-use technologies, offering benefits like reduced contamination risk and improved efficiency, accelerates segment growth.

Microcarrier beads, versatile across cell types, facilitate robust cell attachment and growth with a high surface area to volume ratio, enhancing scalability. Their ease of scaling makes them suitable for substantial cell or biopharmaceutical production. User-friendly, adaptable, and cost-effective microcarrier beads extensively contribute to biopharmaceutical manufacturing, cell therapy applications, and various research areas, including drug discovery and tissue engineering.

Vaccine manufacturing is the most popular application in the microcarrier market owing to vaccine manufacturers' growing adoption of microcarriers.

The increasing prevalence of infectious diseases and a growing awareness of the importance of vaccination have led to a high demand for vaccines, consequently driving the need for microcarriers essential in producing cell-based vaccines. Cell-based vaccine production offers numerous advantages over traditional methods, such as quicker and more efficient production for a broader range of pathogens. Microcarriers are highly advantageous for this objective, as they offer a substantial surface area promoting robust cell attachment and growth. This capacity enables the cultivation of high cell densities within a limited volume, a critical factor in the efficient production of vaccines. This trend is evident in the increasing preference of vaccine manufacturers for microcarriers, driven by the enhanced efficiency and scalability these tools provide.

Pharmaceutical and biotechnology companies are expected to dominate the microcarrier market.

Microcarriers are essential in pharmaceuticals and biotechnology, supporting the production of vaccines, monoclonal antibodies, and biological drugs. The increased need for microcarriers drives the rising demand for these products. Pharmaceutical and biotechnology giants, investing significantly in research and development, consistently introduce innovative microcarrier products, securing a competitive edge. Their global presence allows them to reach a broad customer base, providing a strategic advantage over smaller entities. Moreover, these firms stand to gain from evolving trends, such as the increasing need for cell-based treatments and the swift growth of the biopharmaceutical sector, which amplifies the demand for microcarriers across various applications.

United States is expected to remain dominant in themicrocarrier market.

The United States is the home of renowned pharmaceutical and biotechnology giants, including Pfizer, Johnson & Johnson, and Merck, making these companies substantial consumers of microcarriers. Their significant presence in the U.S. is a crucial driver for the growth of the microcarrier market in the country. The United States strongly emphasizes research and development, resulting in the continual innovation of new microcarrier products and technologies. This allows the country to uphold its competitive standing in the microcarrier market. Also, favorable government policies further support the growth of the pharmaceutical and biotechnology industries, contributing to the overall expansion of the microcarrier market within the United States.

Competitive Landscape

The companies that dominate the global microcarrier market are Thermo Fisher Scientific, Getinge, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Eppendorf AG, Danaher Corporation, Sartorius AG, Lonza Group, and Merck KGaA.

Market Summary

• Product – The report analyses the Microcarrier Market by product from two angles (Equipment and Consumables).
• Application – A Renub Research report on theMicrocarrier Market examines applications from three angles (Cell Therapy, Vaccine Manufacturing, and Others).
• End-User – The report analyses the Microcarrier Market by end-user from three angles: (Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Contract Manufacturing Organizations, and academic and research Institutes).
• Countries – There are 26 different perspectives on the Microcarrier Market by country (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, UAE, and Rest of the World).
• Key Players – Every significant player in the Microcarrier Market has been discussed from three perspectives (Overview, Recent Developments, and Revenue): Thermo Fisher Scientific, Getinge, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Eppendorf AG, Danaher Corporation, Sartorius AG, Lonza Group, and Merck KGaA.

About Us

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research